The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2021 | Exciting updates from ASCO GI 2021
Vivek Subbiah, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, explores upcoming trial updates to be presented at this years American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, including the use of FGFR inhibitors in cholangiocarcinoma, as well as using circulating DNA in the management of gastrointestinal malignancies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
